On June 16, 2025, RemeGen Co., Ltd. ('RemeGen', stock symbols: 688331.SH/09995.HK) announced that telitacicept (RC18; brand ...

Alterations in thyroid gland function result from the action of stimulating or blocking autoantibodies on cell membrane receptors ... a result of a mother with antibodies due to AITD.

A landmark achievement occurred in 2017 with the first approval of chimeric antigen receptor T cell (CAR-T) therapy for relapsed/refractory acute ... representing a paradigm shift in personalized ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth cohorts from the Environmental Influences on Child Health Outcomes Children ...

Dihydroergotamine (DHE) is an older drug used for migraine relief. Learn about new formulations and find out if you're a good candidate for this powerful treatment.